Oncology
5,185 studies511 in 7 days2,486 in 30 days
Filters
Latest
5,185 studies
- Inhibition of Bone Morphogenetic Protein 2 Suppresses the Stemness Maintenance of Cancer Stem Cells in Hepatocellular Carcinoma via the MAPK/ERK Pathway [Retraction].
- Long-Noncoding RNA PCAT6 Aggravates Osteosarcoma Tumourigenesis via the MiR-143-3p/ZEB1 Axis [Retraction].
- The Effects of Different Storage Temperatures on Chemical Substance Changes in Saffron Stigmas Analyzed by LC-MS and GC-TOF-MS.
- Skeletal Muscle Index and Baseline Biomarkers in Atezolizumab-Treated Extensive-Stage Small-Cell Lung Cancer: A Real-World Cohort Study.
- Association Between the Number of Invasive Tumor Foci and Axillary Nodal Burden in Multifocal and Multicentric Breast Cancer.
- USFDA Oncology Drug Approvals from 2014- 2025: Comparing non-immunotherapy and immunotherapy approvals, their endpoints, and their efficacy.
- AI-based prognosis and chemotherapy benefit in node-positive, HR+ breast cancer: a blinded external validation on SWOG-8814 trial
- Nanotechnology-Enabled Immunotherapy for Colorectal Cancer: Overcoming the "Cold" Tumor Microenvironment in Microsatellite-Stable Disease.
- Association Between Serum 25-Hydroxyvitamin D Levels and Immune-Related Adverse Events During PD-1/PD-L1 Inhibitor Therapy: A Retrospective Study.
- Next-Generation CAR-T Cell Therapy: From Modular Design to Clinical Expansion.
- CALLY is not associated with colorectal polyps risk: a systematic evaluation and mechanism exploration controlling for traditional factors and Traditional Chinese Medicine constitution
- Machine learning to predict osteoradionecrosis in head and neck cancer
- The consolidation paradox: rethinking thoracic radiotherapy in extensive-stage small cell lung cancer in the immunotherapy era
- Optimizing first-line therapy for advanced EGFR-mutated NSCLC: a patient-centered approach for low- and middle- income countries
- HAX1 in cancer: from molecular scaffolding to therapeutic targeting
- Editorial: Roles of metabolism, immunity, and microbiome in the pathophysiology of the breast cancer microenvironment
- PD-1/PD-L1 inhibitors in the treatment of pMMR mCRC: a meta-analysis based on randomized controlled trials
- Muscle strength and muscle mass phenotypes and survival in unresectable hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy-based combination therapy
- Perineural invasion is associated with an aggressive phenotype and reduced in vitro capecitabine sensitivity in colorectal cancer
- Integrated fecal SDC2 methylation and serum tumor markers improve noninvasive detection of colorectal cancer
- Identifying a novel variant in ELOC (TCEB1)-mutant renal cell carcinoma: a case report and literature review
- Nilotinib targets NEIL3-mediated fatty acid oxidation to promote anoikis in hepatocellular carcinoma cells
- Two case reports of small cell lung cancer: typical CT manifestations, with one case illustrating adjunctive CT-based diagnosis without pathological confirmation
- From cancer safety signals to cardio-oncology translation: a dual-database bibliometric and BERTopic semantic analysis of SGLT2 inhibitor research in oncology (2014–2026)
- Erianin suppresses prostate cancer progression and attenuates STAT3 signaling